LIQUID FORMULATIONS OF PHOSPHOLIPASE ENZYME INHIBITORS

The present invention is directed to liquid formulations of inhibitors of phospholipase enzymes, such as cytosolic PLA2, compositions containing the same and processes for manufacture thereof.

Saved in:
Bibliographic Details
Main Authors DONAHUE FRANCES ANNE, KU MANNCHING SHERRY
Format Patent
LanguageEnglish
Published 18.03.2010
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to liquid formulations of inhibitors of phospholipase enzymes, such as cytosolic PLA2, compositions containing the same and processes for manufacture thereof.
Bibliography:Application Number: US20070513046